SBIR/STTR Research Award

ISOLATION OF PENICILLIN-RESISTANT STRAINS OF NEISSERIA GONORRHOEAE AND HAEMOPHILUS INFLUENZAE HAS INCREASED SUBSTANTIALLY IN THE U.

Award identifier 856ac2d0341b04301507bf3c4e3d48772f37335b900d3cd86addad3866bc2abcAwarding agency Department of Health and Human Services

Award amount

$50,000

Program and phase

SBIR · Phase I

Award year

1984

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
Not reported
Recipient company
Genetic Systems Corp
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
Not reported
Topic code
Not reported

Research abstract

ISOLATION OF PENICILLIN-RESISTANT STRAINS OF NEISSERIA GONORRHOEAE AND HAEMOPHILUS INFLUENZAE HAS INCREASED SUBSTANTIALLY IN THE U.S. OVER THE LAST FEW YEARS. IN SOME REGIONS THIS RAPID INCREASE IN THE NUMBER OF RESISTANT STRAINS HAS HEIGHTENED THE CONCERN OF PUBLIC HEALTH AGENCIES AND HAS RESULTED IN REVISED METHODS OF CONTROL. IF THE SPREAD OF RESISTANT STRAINS IS NOT ADEQUATELY CONTROLLED, THIS FAILURE WILL BE REFLECTED IN HIGHER INCIDENCES OF DISEASE AND INCREASED COSTS OF TREATMENT WITH ALTERNATIVE ANTIBIOTICS. ONE IMPROVEMENT IN THE METHODS FOR CONTROL WOULD BE TO PROVIDE A MEANS OF MORE RAPID BACTERIAL DETECTION AND IDENTIFICATION OF RESISTANCE FACTORS. THIS METHOD MUST BE FASTER THAN THE 2-4 DAYS NECESSARY FOR CULTURE-DEPENDENT TECHNIQUES BUT POSSESS A SIMILAR DEGREE OF ACCURACY AND SENSITIVITY. WE INTEND TO DEVELOP A DIRECT, CULTURE-INDEPENDENT ASSAY UTILIZING MONOCLONAL ANTIBODIES. SINCE RESISTANCE IS CONFERRED BY UNIQUE, PLASMID-ENCODED PROTEINS (I.E., BETA-LACTAMASE) TARGET MOLECULES CAN BE IDENTIFIED BY A SENSITIVE IMMUNOFLUORESCENCE ASSAY TO STAIN INDIVIDUAL BACTERIA IN A DIRECT PATIENT SMEAR. FOR THIS PURPOSE, WE WILL UTILIZE MONOCLONAL ANTIBODIES DIRECTED AGAINST TWO "FUNCTIONAL" TARGETS. THE FIRST WILL PROVIDE THE PHYLOGENETIC IDENTIFICATION OF THE BACTERIA (I.E., ANTIBODIES TO MEMBRANE PROTEINS OR LPS), AND THE SECOND WILL IDENTIFY THE SPECIFIC PLASMID-ENCODED RESISTANCE FACTOR (I.E., ANTIBODY TO BETA-LACTAMASE). PATIENT SPECIMEN WILL BE SMEARED ONTO MICROSCOPE SLIDES, FIXED, AND STAINED WITH THE ANTIBODIES. THE SLIDES WILL THEN BE SCANNED UNDER A FLUORESCENCE MICROSCOPE FOR THE PRESENCE OF STAINED ORGANISMS. SINCE BETA-LACTAMASE ACCUMULATE IN THE PERIPLASMIC SPACES BETWEEN THE CELL WALL AND OUTER MEMBRANE, IT MAY BE POSSIBLE TO IDENTIFY THE BACTERIA POSSESSING THE RESISTANCE FACTOR BY A CHARACTERISTIC STAINING MORPHOLOGY. WE SHOULD BE ABLE TO PERFORM THE TEST IN LESS THAN AN HOUR WITH A DEGREE OF SENSITIVITY AND ACCURACY COMPARABLE TO CULTURE.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.